UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
Journal of the American College of Cardiology, ISSN 0735-1097, 09/2013, Volume 62, Issue 10, pp. 909 - 917
atherosclerosis | FDG | plaque | inflammation | atorvastatin | statins | Cardiac & Cardiovascular Systems | Life Sciences & Biomedicine | Cardiovascular System & Cardiology | Science & Technology | Cardiology. Vascular system | Heart | Biological and medical sciences | Medical sciences | Atherosclerosis (general aspects, experimental research) | Blood and lymphatic vessels | Hydroxymethylglutaryl-CoA Reductase Inhibitors - administration & dosage | Plaque, Atherosclerotic - diagnostic imaging | Heptanoic Acids - therapeutic use | Humans | Middle Aged | Male | Feasibility Studies | Atherosclerosis - diagnostic imaging | Inflammation - drug therapy | Pyrroles - administration & dosage | Multimodal Imaging - methods | Aged, 80 and over | Heptanoic Acids - administration & dosage | Adult | Female | Inflammation - diagnostic imaging | Pyrroles - therapeutic use | Aorta, Thoracic - pathology | Atherosclerosis - drug therapy | Double-Blind Method | Treatment Outcome | Positron-Emission Tomography - methods | Atorvastatin Calcium | Carotid Arteries - diagnostic imaging | Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use | Fluorodeoxyglucose F18 | Aged | Carotid Arteries - pathology | Plaque, Atherosclerotic - drug therapy | Aorta, Thoracic - diagnostic imaging | Index Medicus | Abridged Index Medicus
Journal Article
Circulation research, ISSN 0009-7330, 2014, Volume 114, Issue 1, pp. 214 - 226
atherosclerosis | macrophages | neutrophils | necrotic core | efferocytosis | Cardiac & Cardiovascular Systems | Peripheral Vascular Disease | Life Sciences & Biomedicine | Hematology | Cardiovascular System & Cardiology | Science & Technology | Macrophages - physiology | Plaque, Atherosclerotic - metabolism | Anti-Inflammatory Agents - pharmacology | Humans | Neutrophils - drug effects | Neutrophils - physiology | Apolipoproteins E - metabolism | Macrophages - metabolism | Animals | Apolipoproteins E - genetics | Cell Death | Anti-Inflammatory Agents - therapeutic use | Macrophages - drug effects | Plaque, Atherosclerotic - drug therapy | Neutrophils - metabolism | Disease Models, Animal | Index Medicus
Journal Article
Atherosclerosis, ISSN 0021-9150, 2014, Volume 233, Issue 2, pp. 601 - 607
Cardiovascular | mTOR | Rapamycin | Everolimus | Autophagy | Atherosclerosis | Drug-eluting stent | MTOR | Cardiac & Cardiovascular Systems | Peripheral Vascular Disease | Life Sciences & Biomedicine | Cardiovascular System & Cardiology | Science & Technology | Metformin - therapeutic use | Apolipoproteins E - deficiency | Cholesterol - blood | Humans | Coronary Artery Disease - blood | TOR Serine-Threonine Kinases - antagonists & inhibitors | Tissue Scaffolds | Rupture, Spontaneous - prevention & control | Drug Interactions | Hyperglycemia - chemically induced | Swine | Coronary Artery Disease - pathology | Receptors, LDL - deficiency | Dyslipidemias - prevention & control | Plaque, Atherosclerotic - blood | Drug Evaluation, Preclinical | Drug Therapy, Combination | Plaque, Atherosclerotic - pathology | Sirolimus - adverse effects | Hyperglycemia - prevention & control | Rabbits | Drug-Eluting Stents | Sirolimus - analogs & derivatives | Sirolimus - therapeutic use | AMP-Activated Protein Kinases - antagonists & inhibitors | Metformin - pharmacology | Clinical Trials as Topic | Coronary Artery Disease - drug therapy | Sirolimus - pharmacology | Absorbable Implants | Mice, Knockout | Animals | Hydroxymethylglutaryl-CoA Reductase Inhibitors - pharmacology | Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use | Dyslipidemias - chemically induced | Triglycerides - blood | Macrophages - drug effects | Mice | Plaque, Atherosclerotic - drug therapy | Hyperglycemia | Hypoglycemic agents | Statins | Index Medicus
Journal Article
Diabetologia, ISSN 0012-186X, 03/2014, Volume 57, Issue 3, pp. 633 - 642
Inflammation | Diabetes | NOX | Atherosclerosis | Immune system | Medicine & Public Health | Human Physiology | Metabolic Diseases | Internal Medicine | Life Sciences & Biomedicine | Endocrinology & Metabolism | Science & Technology | Cardiology. Vascular system | Diabetes. Impaired glucose tolerance | Atherosclerosis (general aspects, experimental research) | Biological and medical sciences | Endocrinopathies | Etiopathogenesis. Screening. Investigations. Target tissue resistance | Medical sciences | Blood and lymphatic vessels | Endocrine pancreas. Apud cells (diseases) | Immunohistochemistry | Inflammation - pathology | Diabetes Mellitus, Experimental - drug therapy | Reactive Oxygen Species - metabolism | Apolipoproteins E - deficiency | Male | Diabetic Angiopathies - pathology | Inflammation - drug therapy | NADPH Oxidases - drug effects | Aorta, Thoracic - drug effects | NADPH Oxidases - biosynthesis | Plaque, Atherosclerotic - pathology | Aorta, Thoracic - pathology | Pyrazoles - pharmacology | Oxidation-Reduction | Inflammation - immunology | Diabetic Angiopathies - drug therapy | Plaque, Atherosclerotic - immunology | Diabetes Mellitus, Experimental - immunology | Animals | Diabetic Angiopathies - immunology | Diabetes Mellitus, Experimental - pathology | Mice | Pyridines - pharmacology | Plaque, Atherosclerotic - drug therapy | Index Medicus
Journal Article
Redox biology, ISSN 2213-2317, 08/2017, Volume 12, pp. 18 - 34
Angiogenesis | Hypercholesterolemia | Neovascularization | VEGF | Atherosclerosis | Life Sciences & Biomedicine | Biochemistry & Molecular Biology | Science & Technology | Animals | Oxidative Stress | Plaque, Atherosclerotic - metabolism | Neovascularization, Pathologic - drug therapy | Humans | Angiogenesis Inhibitors - pharmacology | Angiogenesis Inhibitors - therapeutic use | Clinical Trials as Topic | Neovascularization, Pathologic - metabolism | Plaque, Atherosclerotic - drug therapy | Plaque, Atherosclerotic - pathology | Disease Progression | Index Medicus | Life Sciences
Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 12/2008, Volume 52, Issue 23, pp. 1847 - 1857
atherosclerosis | INCREASES COLLAGEN CONTENT | INCREASED EXPRESSION | EXPERIMENTAL ATHEROMA | DEFICIENT MICE | molecular imaging | CORONARY-ARTERY | UMCG Approved | IN-VIVO | HMG coenzyme reductase inhibitor | CAROTID PLAQUES | matrix metalloproteinase | VULNERABLE PLAQUE | POTENTIAL ROLE | ACUTE PLAQUE DISRUPTION | Cardiology. Vascular system | Biological and medical sciences | Medical sciences | Atherosclerosis (general aspects, experimental research) | Blood and lymphatic vessels | Immunohistochemistry | Rabbits | Atherosclerosis - pathology | Tomography, Emission-Computed, Single-Photon - methods | Atherosclerosis - drug therapy | Models, Chemical | Male | Combined Modality Therapy | Atherosclerosis - diet therapy | Technetium - pharmacology | Macrophages - metabolism | Animals | Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use | Matrix Metalloproteinase Inhibitors | Matrix Metalloproteinase 2 - chemistry | Aorta, Abdominal - pathology | Matrix Metalloproteinase 9 - chemistry | High cholesterol diet | Technetium isotopes | Radioactive tracers | Technetium | Matrix metalloproteinase | Macrophages | Dosage | Fluvastatin | Computed tomography | Imaging | Atherosclerosis | Tomography | Aorta | Metalloproteinase | Lesions | Plaques | Statins | Photon emission | Enzymes | Medical imaging | Feasibility studies | Single photon emission computed tomography | Cholesterol | Molecular chains | Gelatinase B | Abdomen | Gelatinase A | Diet | Arteriosclerosis | Collagen | Coronary vessels | Infiltration | Laboratory animals | Immunoassays | Veins & arteries | Index Medicus | Abridged Index Medicus
Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 2014, Volume 64, Issue 21, pp. 2207 - 2217
Cardiovascular | Internal Medicine | atherosclerosis | macrophage | vulnerable plaque | statin therapy | Cardiac & Cardiovascular Systems | Life Sciences & Biomedicine | Cardiovascular System & Cardiology | Science & Technology | Cardiovascular agents | Antilipemic agents | Heart attacks | Angina pectoris | Drug therapy | Cholesterol | Statins
Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 06/2015, Volume 65, Issue 22, pp. 2404 - 2415
atherothrombosis | plaque rupture | antithrombotic | glycoprotein VI | Cardiac & Cardiovascular Systems | Life Sciences & Biomedicine | Cardiovascular System & Cardiology | Science & Technology | Carotid Arteries - drug effects | Carotid Stenosis - etiology | Plaque, Atherosclerotic - complications | Plaque, Atherosclerotic - diagnosis | Humans | Carotid Stenosis - drug therapy | Rats | Carotid Stenosis - physiopathology | Immunoglobulin Fab Fragments - pharmacology | Animals | Carotid Arteries - physiopathology | Platelet Membrane Glycoproteins - pharmacology | Carotid Arteries - pathology | Platelet Activation - drug effects | Plaque, Atherosclerotic - drug therapy | Blood Flow Velocity - physiology | Immunologic Factors - pharmacology | Blood Flow Velocity - drug effects | Proline | Atherosclerotic plaque | Collagen | Immunoglobulin G | Adenosine triphosphatase | Von Willebrand factor | Index Medicus | Abridged Index Medicus | Fc, fragment crystallizable region of IgG | Ig, immunoglobulin | TxA2, thromboxane A2 | GPO, glycine-proline-hydroxyproline | GPVI, glycoprotein VI | vWF, von Willebrand factor | plaque rupture | KD, dissociation constant | ADP, adenosine diphosphate | Original Investigation
Journal Article